SPINK1 mutation in a pediatric patient with chronic pancreatitis: A case report  by Ruiz-Navas, P. et al.
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tación de SPINK1 en paciente pediátrico
n pancreatitis crónica. Reporte de un caso
ronic  pancreatitis  is  a  progressive  inﬂammatory  process
the  pancreas  that  leads  to  ﬁbrosis  and  exocrine  and
docrine  function  loss  with  structural  changes  demon-
ated  by  radiologic  and  histologic  evidence.1,2
The  clinical  course  of  the  disease  is  characterized  by
urrent  episodes  of  acute  pancreatitis  appearing  at  early
Table  1  Paraclinical,  imaging,  and  genetic  studies
performed.
Paraclinical  Second  episode  Third  episode
Calcium  9.4  mg/dl  9.9  mg/dl
Amylases  1,648-488-281-
110-85
IU/l
1,359-139  U/l
Amylase  in  urine  343  --
Lipases  2,639-490-296-96-
50
U/l
3,098-221  IU/l
Albumin  3.7  g/dl --
Alkaline  phosphatase 169  IU/l --
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enes,  followed  by  a  ﬁnal  stage  with  calciﬁcations,  pancre-
c  insufﬁciency,  and  diabetes  mellitus  in  the  majority  of
 patients.1
Chronic  pancreatitis  incidence  due  to  any  cause  is  from
-10/100,000  inhabitants/year  in  Europe  and  the  United
tes.3 Its  cause  cannot  be  deﬁned  in  a  signiﬁcant  per-
ntage  of  cases  (10-25%),  resulting  in  the  classiﬁcation  of
opathic  chronic  pancreatitis.  This  is  the  classiﬁcation  in
-60%  of  pediatric  cases.4
Over  the  last  few  decades,  in  addition  to  the  cystic
rosis  transmembrane  conductance  regulator  (CFTR)  gene,
erations  have  been  identiﬁed  in  others,  such  as  the
tionic  trypsinogen  (PRSS1),  anionic  trypsinogen  (PRSS2),
ine  protease  inhibitor  Kazal  type  1  (SPINK1),  and  chy-
trypsin  C  (CTRC)  genes  that  play  an  important  role  in
 pathophysiology  of  chronic  pancreatitis,  reducing  the
rcentage  of  cases  previously  deﬁned  as  idiopathic.4,5
We  present  herein  the  case  of  an  8-year-old  boy  that  was
mitted  to  the  Hospital  Pablo  Tobón  Uribe  due  to  localized
dominal  pain  in  the  epigastrium,  nausea,  and  vomiting.
 nutritional  status  was  adequate,  epigastrium  palpation
s  painful,  but  there  were  no  other  pathologic  signs.  He
d  a  past  history  of  an  episode  of  acute  pancreatitis  at  the
e  of  7  years  and  his  family  history  included  a  brother  with
ute  pancreatitis  and  no  other  relevant  data.  The  patient’s
ptoms  upon  admittance  were  suggestive  of  uncompli-
ted  acute  pancreatitis  and  he  had  elevated  pancreatic
zymes  (amylase  1,359;  lipase  3,098)  (table  1).  A  nuclear
gnetic  resonance  study  of  the  pancreas  revealed  irregular
ation  of  the  duct  of  Wirsung  (ﬁg.  1).  Taking  his  past  history
d  the  biochemical  and  radiologic  ﬁndings  into  account,
 diagnostic  approach  for  chronic  pancreatitis  was  begun,
ing  out  other  causes  such  as  hypercalcemia  and  autoim-
ne  pancreatitis;  the  quantiﬁcation  of  immunoglobulin  G
class  4  was  within  normal  parameters.  Molecular  studies
re  performed  that  included  60  mutations  for  CFTR,  which
re  negative,  and  only  the  presence  of  the  N34S  muta-
n  of  the  SPINK1  gene  in  exon  3  was  reported.  During  the
e  year  of  follow-up  at  the  institution,  the  patient  once
ain  presented  with  symptoms  of  uncomplicated  acutePlease cite this article as: Ruiz-Navas P, Contreras-Ramirez
 Montero-Carvajalino AE, Castan˜o-Jaramillo LM, Orozco-Forero
 Mutación de SPINK1 en paciente pediátrico con pancreatitis
nica. Reporte de un caso. Revista de Gastroenterología de Méx-
. 2015;80:223--225.
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glutamyltransferase
14  U/l  13  U/l
holesterol  169  mg/dl  184  mg/dl
riglycerides  182  mg/dl  105  mg/dl
lycemia  86  mg/dl  56-89-97  mg/dl
DH --  200  mg/dl
UN 9  mg/dl  7.7  mg/dl
RP 1.26  mg/dl  0.11  mg/dl
SR 13  mm/h  --
eukocytes  3,800/m3 6,600/m3
eutrophils  57%  64%
latelets  188,000/m3 287,000/m3
ntophoresis  Negative
tool  analysis No  fats
FTR  (60  mutations)  Negative
RSS1  (exon  2  and  3) Negative
PINK1  (exon  3)  C.  101A  >  G/p.
Asn34Ser.
munoglobulin  G
subclass  4
12  mg/dl
ontrast  and
non-contrast
magnetic
resonance
cholangiography
Pancreas  with
beading  of  the
duct  of  Wirsung,
normal
parenchyma.  No
congenital
biliopancreatic
abnormalities  or
lithiasis
omplete  abdominal
ultrasound
Normal
UN: blood urea nitrogen; CFTR: cystic ﬁbrosis transmembrane
onductance regulator; CRP: C-reactive protein; ESR: erythro-
yte sedimentation rate; LDH: lactate dehydrogenase; PRSS1:
ationic trypsinogen; SPINK1: serine protease inhibitor Kazal
ype 1.
ncreatitis  and  he  has  not  presented  with  evidence  of
docrine  or  exocrine  insufﬁciency.This  patient  has  had  3  episodes  of  acute  pancreatitis
th  asymptomatic  intercritical  periods,  irregular  dilation
the  duct  of  Wirsung  revealed  by  imaging  studies,  and
ntiﬁcation  of  the  N34S  mutation  of  the  SPINK1  gene.
is  mutated  gene  has  been  associated  with  recurrent  acute
224  SCIENTIFIC  LETTERS
Figure  1  Contrast-enhanced  magnetic  resonance  cholangiog-
raphy  image.  A)  Focal  stricture  zone.  B)  Dilation.  Image  of
beading  of  the  duct  of  Wirsung.
pancreatitis,  as  well  as  with  hereditary  chronic,  alcoholic,
tropical  calcifying,  and  idiopathic  pancreatitis.3 It  has  also
been  associated  with  higher  rates  of  pancreatic  lithiasis,
pseudocysts,  and  calciﬁcations.4 Likewise,  it  has  been  seen
in  a  small  percentage  of  asymptomatic  controls  and  in  other
pancreatic  pathologies,  suggesting  that  these  mutations  are
modifying  factors,  rather  than  causes,  of  the  disease.  In
our  case,  the  SPINK1  alteration  was  the  only  cause  that
could  be  attributed,  with  the  limitation  that  other  genes,
such  as  the  CTRC,  and  other  exons  of  the  PRSS1,  were  not
studied.
The  most  frequent  clinical  presentation  is  early  age
onset,  around  10  years  of  age,  with  intermittent  symp-
toms  of  nausea  and  vomiting,  in  which  the  abdominal  pain
may  or  may  not  be  the  main  symptom,  and  a  slow  progres-
sion  toward  pancreatic  insufﬁciency  and  endocrine  function
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Figure  2  Pathophysiology  of  chronic  pancreatitis  and  its
genetic bases.  CTRC:  chymotrypsin  C;  PRSS1:  cationic  trypsino-
gen; PRSS2:  anionic  trypsinogen;  SPINK1:  serine  protease
inhibitor  Kazal  type  1.  Adapted  from  Derikx  et  al.7
The  prevalence  of  hereditary  chronic  pancreatitis  is  low
in  the  pediatric  population.  Its  diagnosis  is  limited  due  to  a
low  rate  of  suspicion  and  the  difﬁculty  in  our  environment
of  identifying  the  speciﬁc  gene  mutations,5 giving  relevance
to  the  publication  of  clinical  cases  such  as  this  one.  Descrip-
tions  of  the  typical  characteristics  of  this  pathology  and  a
complete  diagnostic  approach  enable  possible  complications
to  be  anticipated,  environmental  risk  factors  to  be  avoided,
and  family  genetic  counseling  to  be  provided.
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0,compromise  that  can  occur  at  more  advanced  ages,  wit
radiologic  evidence  of  structural  changes  (irregular  dilatio
of  the  pancreatic  ducts,  atrophy,  glandular  calciﬁcation,  an
peripancreatic  fat  alterations).2,3,5,6
The  pathophysiologic  process  of  this  entity  is  still  unde
study.  Current  ﬁndings  point  to  a  process  of  autodigestio
due  to  the  premature  activation  of  trypsinogen  seconda
to  mutations  in  the  genes  that  encode  proteins  that  ar
in  charge  of  keeping  it  inactive  while  it  is  in  the  pancrea
(ﬁg.  2).  PRSS1  alterations  have  been  described  as  the  ma
mutations  associated  with  chronic  pancreatitis,  but  in  th
last  few  years,  association  with  other  genes,  such  as  th
PRSS2,  SPINK1,  and  CTRC,  has  been  described.7--9
SPINK1  acts  as  the  ﬁrst  line  of  defense  against  trypsinoge
and  is  capable  of  inhibiting  around  20%  of  the  total  activity  o
trypsin  within  the  pancreas.  The  most  commonly  implicate
mutation  of  this  gene  is  the  N34S  mutation,  according  t
recent  data  from  genetic  studies  of  patients  with  chron
hereditary  and  idiopathic  pancreatitis.3,5,6,10
The  prevalence  of  these  mutations  varies  in  accordanc
with  the  geographic  area.  Latin  American  case  series  hav
been  published  that  report  these  gene  mutations  in  the
pediatric  population  with  recurrent  pancreatitis;  the  most
frequent  is  the  PRSS1  gene  mutation,  whereas  the  SPINK1-
NS34  mutation  has  been  found  in  very  few  cases.11--13No  ﬁnancial  support  was  received  in  relation  to  this  article
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no  recurrence,  no  infection,  and  with  epithelialization.  The
histopathologic  study  reported  ‘‘hidradenitis  suppurativa’’.
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fermedad de Verneuil. Presentación de un
so y  revisión de la  literatura
64-year-old  man  had  a  past  history  of  poorly  controlled
e  2  diabetes  mellitus  of  18-year  progression,  alcoholism,
d  severe  smoking.  He  presented  with  an  abscess  in  the
t  perianal  region  10  years  prior,  with  pain,  edema,  ery-
ma,  and  spontaneous  drainage  8  days  later;  at  present,
cording  to  the  patient,  symptoms  are  imperceptible  but
re  is  a  constant  scant  purulent  to  serous  discharge.
ysical  examination  revealed  irregular  widespread  involve-
nt  of  the  bilateral  gluteal,  perianal,  and  scrotal  areas,
th  the  presence  of  subcutaneous  nodules,  amorphous  and
egular  scars,  dermal  abscesses  with  secondary  ﬁbrosis,
uses  and/or  ulcers,  contracture,  and  induration  of  the
n  (Fig.  1).  No  anal  duct  involvement  was  identiﬁed  in
 proctologic  revision.  Laboratory  work-up  was  normal
d  culture  of  the  purulent  matter  reported  Escherichia
li.  Intra-anal  ultrasound  revealed  ‘‘ﬁstulous’’  tracts  with
 communication  with  the  anal  duct.  Surgical  treatment
s  radical  resection  of  the  complete  thickness  of  all  the
ected  skin  with  a  2  cm  margin  that  extended  to  the
cutaneous  fat,  leaving  only  healthy  tissue  (Fig.  2).
e  postoperative  period  was  satisfactory  and  the  patient
s  released  72  h  after  surgery,  with  only  sitz  baths  carried
t  for  the  secondary  wound,  and  follow-up  at  10  months
til  the  deﬁnitive  cure  and  release  (Figs.  3  and  4) withPlease cite this article as: García-Sánchez MA, Santillan-
llano EG. Enfermedad de Verneuil. Presentación de un caso y
isión de la literatura. Revista de Gastroenterología de México.
5;80:225--227.
Fig
gluVerneuil’s  disease  is  a  rare  pathology  of  unknown  eti-
gy.  The  ﬁrst  case  was  described  in  1839  by  Velpeau,
t  it  was  not  until  1854  that  it  was  clinically  identiﬁed
 Verneuil.1 It  is  characterized  by  nodular  inﬂammation
d  chronic  infection  of  the  apocrine  glands,  ‘‘ﬁstulas’’,ure  1  Hidradenitis  suppurativa  involving  the  bilateral
teal,  perianal,  and  scrotal  areas.
